Related Experiment Video
Updated: Nov 22, 2025
10:06
Author Spotlight: Porphyrin-Modified Beads for Use as Compensation Controls in Flow Cytometry
Published on: March 24, 2023
2.8K
Porphyrinoid Drug Conjugates.
Jonathan F Arambula1,2, Jonathan L Sessler1
1Department of Chemistry, University of Texas at Austin, Austin, TX 78712-1224, USA.
Chem
|January 11, 2021
Summary
Synthetic porphyrinoids offer new avenues for developing targeted drug conjugates. These novel compounds, including texaphyrins, show promise for improved efficacy and reduced side effects in cancer therapy.
Area of Science:
- Medicinal Chemistry
- Organic Chemistry
- Biotechnology
Background:
- Nature-inspired drug discovery is crucial for future therapies.
- Porphyrins, vital biological pigments, have unique properties for medical applications.
- Drug conjugates enhance therapeutic efficacy and minimize side effects.
Purpose of the Study:
- To explore synthetic porphyrinoids as a basis for novel drug conjugates.
- To highlight improved medicinal and site-localizing properties of these systems.
- To emphasize cancer-targeting platinum-containing conjugates using texaphyrins.
Main Methods:
- Synthesis and functionalization of porphyrinoids (texaphyrins, corroles, porphycenes).
- Development of drug conjugates by linking porphyrinoids with therapeutic agents.
- Evaluation of medicinal and site-localizing properties of the resulting conjugates.
Main Results:
- Synthetic porphyrinoids yield drug conjugates with enhanced properties.
- Texaphyrin-based conjugates show promise for cancer targeting with platinum.
- Corroles and porphycenes also demonstrate potential in conjugate development.
Conclusions:
- Porphyrinoids represent a versatile platform for creating advanced drug conjugates.
- This approach offers a generalizable strategy for developing targeted therapies.
- Synthetic porphyrinoids hold significant promise for next-generation cancer treatments.
Related Concept Videos
01:14Drug Metabolism: Phase II Reactions
4.6K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
4.6K
01:14Phase II Conjugation Reactions: Overview
548
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
548
01:19Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
670
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...
670
01:19Phase II Reactions: Miscellaneous Conjugation Reactions
210
Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
210
01:30Prodrugs
3.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
3.6K
02:50Conjugated Proteins
24.1K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
24.1K